Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.

Lisa Mosconi, Michelle Walters, Joanna Sterling, Crystal Quinn, Pauline McHugh, Randolph E Andrews, Dawn C Matthews, Christine Ganzer, Ricardo S Osorio, Richard S Isaacson, Mony J De Leon, Antonio Convit

Journal: BMJ open 2018;8(3):e019362

PMID: 29574441

Plain Language Summary

plain language summary logo

Alzheimer’s disease (AD) is the most common form of dementia, affecting nearly 34 million people worldwide. It has been estimated that one in every three cases of AD may be attributable to diet and lifestyle factors. The aim of this study was to investigate the effects of lifestyle and vascular-related risk factors for AD. Researchers studied the brain scans of 116 healthy adults aged 30-60 years. They collected information on factors related to lifestyle, such as diet, physical activity and intellectual enrichment. They also looked at markers for vascular risk such as body mass index (BMI), cholesterol and homocysteine, as well as cognitive function. The researchers found that a Mediterranean-style diet and good insulin sensitivity were both associated with a healthier brain structure. A better score for intellectual enrichment and lower BMI were both associated with better cognition. They concluded that adopting a Mediterranean-style diet and maintaining a healthy weight might reduce the risk of developing AD.

Abstract

OBJECTIVE

To investigate the effects of lifestyle and vascular-related risk factors for Alzheimer's disease (AD) on in vivo MRI-based brain atrophy in asymptomatic young to middle-aged adults.

DESIGN

Cross-sectional, observational.

SETTING

Broader New York City area. Two research centres affiliated with the Alzheimer's disease Core Center at New York University School of Medicine.

PARTICIPANTS

We studied 116 cognitively normal healthy research participants aged 30-60 years, who completed a three-dimensional T1-weighted volumetric MRI and had lifestyle (diet, physical activity and intellectual enrichment), vascular risk (overweight, hypertension, insulin resistance, elevated cholesterol and homocysteine) and cognition (memory, executive function, language) data. Estimates of cortical thickness for entorhinal (EC), posterior cingulate, orbitofrontal, inferior and middle temporal cortex were obtained by use of automated segmentation tools. We applied confirmatory factor analysis and structural equation modelling to evaluate the associations between lifestyle, vascular risk, brain and cognition.

RESULTS

Adherence to a Mediterranean-style diet (MeDi) and insulin sensitivity were both positively associated with MRI-based cortical thickness (diet: β≥0.26, insulin sensitivity β≥0.58, P≤0.008). After accounting for vascular risk, EC in turn explained variance in memory (P≤0.001). None of the other lifestyle and vascular risk variables were associated with brain thickness. In addition, the path associations between intellectual enrichment and better cognition were significant (β≥0.25 P≤0.001), as were those between overweight and lower cognition (β≥-0.22, P≤0.01).

CONCLUSIONS

In cognitively normal middle-aged adults, MeDi and insulin sensitivity explained cortical thickness in key brain regions for AD, and EC thickness predicted memory performance in turn. Intellectual activity and overweight were associated with cognitive performance through different pathways. Our findings support further investigation of lifestyle and vascular risk factor modification against brain ageing and AD. More studies with larger samples are needed to replicate these research findings in more diverse, community-based settings.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Address: Department of Neurology, Weill Cornell Medical College, New York City, New York, USA.; Department of Psychiatry, New York University School of Medicine, New York City, New York, USA.; Department of Nutrition and Food Studies, New York University Steinhardt School of Public Health, New York City, New York, USA.; Department of Nutrition and Food Studies, New York University Steinhardt School of Public Health, New York City, New York, USA.; Department of Psychology, New York University, New York City, New York, USA.; Department of Psychiatry, New York University School of Medicine, New York City, New York, USA.; ADM Diagnostics, Chicago, Illinois, USA.; Hunter-Bellevue School of Nursing, Hunter College, The City University of New York, New York City, New York, USA.; Department of Neurology, Weill Cornell Medical College, New York City, New York, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.